Quoin Pharmaceuticals

(NASDAQ) QNRX

Current Price$4.23

Market Cap$8.94M

Since IPO (2021)-100%

5 Year-100%

1 Year-51%

1 Month-30%

Quoin Pharmaceuticals Financials at a Glance

Market Cap

$8.94M

Revenue (TTM)

$0.00

Net Income (TTM)

-$16.98M

EPS (TTM)

-$236.73

P/E Ratio

-0.02

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$4.23

Volume

43,780

Open

$4.60

Price

$4.23

Volume

43,780

Open

$4.60

Previous Close

$4.43

Daily Range

$4.11 - $4.82

52-Week Range

$4.11 - $41.80

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$4.23

Volume

43,780

Open

$4.60

Previous Close

$4.43

Daily Range

$4.11 - $4.82

52-Week Range

$4.11 - $41.80

QNRX News

Quoin (QNRX) Q2 Loss Beats Estimates

Motley Fool Markets TeamAug 8, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Quoin Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Michael Myers, PhD

Website

www.quoinpharma.com

Headquarters

Ashburn, VA 20148-7349, US

QNRX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-233%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.94M

Shares Outstanding

1.96M

Volume

43.78K

Avg. Volume

95.30K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$16.29M

EBITDA

-$16.19M

Operating Cash Flow

-$13.54M

Capital Expenditure

$4.00

Free Cash Flow

-$13.54M

Cash & ST Invst.

$3.82B

Total Debt

$0.00

Quoin Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$24.93K

N/A

Gross Margin

0.00%

N/A

Market Cap

$8.94M

N/A

Market Cap/Employee

$2.98M

N/A

Employees

N/A

Net Income

-$4.98M

-30.7%

EBITDA

-$5.09M

-29.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$3.12M

-73.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.08%

N/A

Return on Invested Capital

-1.69%

N/A

Free Cash Flow

-$4.87M

-87.7%

Operating Cash Flow

-$4.87M

-87.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VYNEVYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.$0.66-2.96%

TCRTAlaunos Therapeutics, Inc.

TCRTAlaunos Therapeutics, Inc.$2.62-4.73%

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.49-1.32%

XTLBXTL Biopharmaceuticals Ltd.

XTLBXTL Biopharmaceuticals Ltd.$2.26-1.31%

PMCBPharmaCyte Biotech, Inc.

PMCBPharmaCyte Biotech, Inc.$0.73-3.27%

CYCNCyclerion Therapeutics, Inc.

CYCNCyclerion Therapeutics, Inc.$3.00-0.66%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.64-1.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$16.73-0.01%

INTCIntel

INTCIntel$112.71+0.04%

MRVLMarvell Technology

MRVLMarvell Technology$301.65+0.04%

NVTSNavitas Semiconductor

NVTSNavitas Semiconductor$30.84+0.19%

NUNu Holdings

NUNu Holdings$11.64-0.02%

XOSXos

XOSXos$7.46+2.35%

BBBlackBerry

BBBlackBerry$10.18-0.01%

Questions About QNRX

What is the current price of Quoin Pharmaceuticals?

Quoin Pharmaceuticals is trading at $4.43 per share.

What is the 52-week range for Quoin Pharmaceuticals?

Over the past 52 weeks, Quoin Pharmaceuticals has traded between $4.11 and $41.80.

How much debt does Quoin Pharmaceuticals have?

As of the most recent reporting period, Quoin Pharmaceuticals reported total debt of $0.00.

How much cash does Quoin Pharmaceuticals have on hand?

Quoin Pharmaceuticals reported $3.12M in cash and cash equivalents in its most recent financial results.

What is Quoin Pharmaceuticals’s dividend yield?

Quoin Pharmaceuticals does not currently have a dividend yield.

Quoin Pharmaceuticals

Quoin Pharmaceuticals Financials at a Glance

QNRX News

Quoin (QNRX) Q2 Loss Beats Estimates

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Quoin Pharmaceuticals

QNRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Quoin Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About QNRX

What is the current price of Quoin Pharmaceuticals?

What is the 52-week range for Quoin Pharmaceuticals?

How much debt does Quoin Pharmaceuticals have?

How much cash does Quoin Pharmaceuticals have on hand?

What is Quoin Pharmaceuticals’s dividend yield?

Premium Investing Services